We are live on ! Find out more
IBO

Impact BioMedical
IBO

16 hedge funds and large institutions have $304K invested in Impact BioMedical in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

299% more capital invested

Capital invested by funds: $76.1K → $304K (+$228K)

60% more funds holding

Funds holding: 10 → 16 (+6)

2.43% more ownership

Funds ownership: 0.46% → 2.89% (+2.4%)

Holders
16
Holders Change
+6
Holders Change %
+60%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
–
Closed
1
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$16K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$219K
2
HF
HRT Financial
New York
+$118K
3
Citadel Advisors
Citadel Advisors
Florida
+$104K
4
BlackRock
BlackRock
New York
+$53.1K
5
UBS Group
UBS Group
Switzerland
+$20.6K

Top Sellers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$110K +$219K +126,446 New
HF
2
HRT Financial
New York
$59K +$118K +68,158 New
Citadel Advisors
3
Citadel Advisors
Florida
$52.5K +$104K +60,315 New
BlackRock
4
BlackRock
New York
$26.7K +$53.1K +30,675 New
Geode Capital Management
5
Geode Capital Management
Massachusetts
$20.2K +$4.2K +2,426 +12%
UBS Group
6
UBS Group
Switzerland
$14.1K +$20.6K +11,915 +280%
State Street
7
State Street
Massachusetts
$10.3K +$1.08K +626 +6%
Morgan Stanley
8
Morgan Stanley
New York
$6.79K +$13.5K +7,800 New
TRCT
9
Tower Research Capital (TRC)
New York
$3.28K +$10 +6 +0.2%
Wells Fargo
10
Wells Fargo
California
$895 +$1.73K +1,000 +3,448%
NFSG
11
Newbridge Financial Services Group
Florida
$75 – – –
Bank of America
12
Bank of America
North Carolina
$14 – – –
DB
13
Danske Bank
Denmark
$3 – – –
SRCM
14
Signature Resources Capital Management
California
$3 +$7 +4 New
Group One Trading
15
Group One Trading
Illinois
$1 – – –
FIA
16
FNY Investment Advisers
New York
– -$18K -12,600 Closed
Carson Wealth (CWM LLC)
17
Carson Wealth (CWM LLC)
Nebraska
– +$2 +1 New

IBO Hedge Fund Activity: Q1 2025 in Review

16 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Impact BioMedical (IBO) for Q1 2025, worth a combined $304K — up 299% from $76.1K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new IBO positions and 1 closed out — a net gain of 6 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $219K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $18K sold.

  • 16 institutional investors held Impact BioMedical (IBO) as of Q1 2025, up from 10 in Q4 2024.
  • Funds reported $304K of Impact BioMedical stock for Q1 2025, up 299% quarter-over-quarter.
  • 7 funds opened new Impact BioMedical positions in Q1 2025 and 1 closed out, a net change of +6 holders.
  • The largest Impact BioMedical buyer in Q1 2025 was Vanguard Group, an estimated $219K added.
  • The largest Impact BioMedical seller in Q1 2025 was FNY Investment Advisers, an estimated $18K sold.

Based on aggregated 13F filings for Q1 2025.